Amylyx Pharmaceuticals, Inc. (AMLX) stock
AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$26.62−0.90 (-3.27%)
Close on Nov 18, 2026Market cap $2.97BP/E –Yield –
Amylyx Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Amylyx Pharmaceuticals's pe ratio was 2.6× on Apr 30, 2024.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 2.6× | −538.6 |
| 2023 | Dec 29, 2023 | 541.2× | – |
See a number that looks wrong?